Pancreatic cancer is one of the most deadly malignant tumors for humans. One of the main reasons for its high mortality is the fact that, often, in the initial phases it is asymptomatic, therefore difficult to recognize.
According to recent estimates, the cases of pancreatic cancer diagnosed each year in the world, would be around 280000.
Furthermore - again according to the same statistical studies - this severe malignancy would affect one in 69 people and would have a survival rate of 5 to 6% (ie only 5-6 out of 100 patients are still alive after 5 years after diagnosis). 5 have passed since the diagnosis of the disease).
In our country, about 10, 000 new diagnoses are registered annually. Unlike a time when pancreatic cancer was more prevalent in males, today men and women fall ill equally. The reason is most probably related to the fact that the number of smokers (NB: smoking is an important risk factor) has increased.
This homogeneity between the two sexes is also common to other industrialized countries, such as the United States or the United Kingdom.
According to a US study, between 2010 and 2030, the annual incidence of pancreatic cancer is set to increase by 55%.
